ALLMedicine™ Type 2 Diabetes Center
Research & Reviews 115,591 results
https://doi.org/10.1186/s12875-021-01424-w 10.1186/1756-0500-7-497 10.1155/2016/6989453 10.1016/j.diabres.2020.108072 10.1186/1477-7525-1-13 10.1136/thx.54.7.581 10.1016/j.cnur.2017.04.007 10.1093/gerona/gls161 10.1370/afm.983 10.1016/j.gaceta.2013.03.002 10.1016/j.ccm.2013.10.002 10.1111/dme.12472 10.1016/j.rmed.2016.07.015
BMC Family Practice; Willink RP, Vos RC et. al.
Apr 21st, 2021 - Type 2 diabetes (T2DM) and COPD are chronic medical conditions, for which patients need lifelong healthcare. The aim of this study is to examine in which healthcare setting patients with T2DM and COPD receive their care, and if this is the correct...
https://doi.org/10.1186/s12876-021-01763-z 10.1002/hep.28431 10.1056/NEJMra1503519 10.1002/hep.23527 10.1016/j.jhep.2016.07.033 10.1007/s10620-013-2743-5 10.1002/hep.27368 10.1016/j.diabres.2018.02.023 10.1016/S2213-8587(14)70032-4 10.1038/nrgastro.2013.41 10.1016/S0168-8278(86)80075-7 10.1016/j.cgh.2008.12.015 10.1053/j.gastro.2005.03.084 10.1002/hep.25762 10.1016/j.jhep.2016.06.005 10.1111/apt.13405 10.1177/1403494815602830 10.1093/ije/dyr039 10.1093/sleep/14.6.540 10.1016/0165-1781(89)90047-4 10.1097/ALN.0b013e31816d83e4 10.1007/s11136-011-9903-x 10.1016/j.ultrasmedbio.2010.07.005 10.1002/hep.29367 10.1053/j.gastro.2014.11.039 10.1016/j.metabol.2020.154183 10.1002/hep4.1134 10.1111/obr.12407 10.1038/nrgastro.2013.171 10.2174/1381612826666200310142803 10.1016/j.jhep.2018.03.018 10.1038/srep33386 10.1093/eurheartj/ehr453 10.1002/hep.28253 10.1016/j.atherosclerosis.2016.01.016 10.1002/oby.22210 10.1016/j.jcmg.2016.10.024
BMC Gastroenterology; Nasr P, Iredahl F et. al.
Apr 21st, 2021 - Non-alcoholic fatty liver disease (NAFLD) affects 20-30% of the general adult population. NAFLD patients with type 2 diabetes mellitus (T2DM) are at an increased risk of advanced fibrosis, which puts them at risk of cardiovascular complications, h...
https://doi.org/10.1111/bph.15497
British Journal of Pharmacology; Jones B
Apr 21st, 2021 - Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective treatments for type 2 diabetes as they stimulate insulin release and promote weight loss through appetite suppression. Their main side effect is nausea. All approved GLP-1RAs are f...
https://doi.org/10.1111/tri.13883
Transplant International : Official Journal of the Europe... Ertuglu LA, Porrini E et. al.
Apr 21st, 2021 - Post-transplant diabetes mellitus (PTDM) is a common complication of solid organ transplantation and a major cause of increased morbidity and mortality. Additionally, solid organ transplant patients may have pre-existent type 2 diabetes mellitus (...
https://doi.org/10.1111/dom.14408
Diabetes, Obesity & Metabolism; Heyward J, Christopher J et. al.
Apr 21st, 2021 - Tens of millions of individuals in the United States have Type 2 diabetes, and most require treatment with glucose-lowering medications to manage the disease. To examine trends in non-insulin drug treatment of Type 2 diabetes, including first-line...
Guidelines 405 results
https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/prediabetes-and-type-2-diabetes-mellitus-screening
US Preventative Services Task Force (USPSTF)
Mar 15th, 2021 - According to the Centers for Disease Control and Prevention’s (CDC’s) 2020 National Diabetes Statistics Report, an estimated 13% of all U.S. adults (age ≥18 years) have diabetes, and 34.5% meet criteria for prediabetes.1 The prevalence of prediabe...
https://www.nih.gov/news-events/nih-research-matters/most-covid-19-hospitalizations-due-four-conditions
NIH Research Matters; National Institutes of Health (NIH)
Mar 8th, 2021 - Studies show that certain common medical conditions put people at higher risk for severe illness from COVID-19. These include metabolic disorders like type 2 diabetes and obesity, as well as heart conditions like high blood pressure (hypertension)...
https://www.nih.gov/news-events/nih-research-matters/drug-activates-brown-fat-improves-glucose-metabolism-healthy-women
National Institutes of Health (NIH)
Feb 3rd, 2021 - The majority of adults in the U.S. carry too much fat in their bodies and are now considered overweight or obese. The last several decades have also seen a spike in related diseases of metabolism, such as type 2 diabetes.
https://www.nih.gov/news-events/nih-research-matters/brown-fat-associated-less-heart-metabolic-disease
National Institutes of Health (NIH)
Feb 1st, 2021 - Too much white fat, a characteristic of obesity, has been shown to increase the risk of type 2 diabetes, high blood pressure, and other diseases. A less common type of fat, called brown fat, uses blood sugar and fat molecules to create heat and he...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785422/
Obesity Medicine; Pang J, Liu M et. al.
Jan 5th, 2021 - COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 di...
Drugs 2,593 results see all →
Clinicaltrials.gov 125,107 results
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86acdd9e-8637-43e4-8bf7-b3a123b871b8
Aug 12th, 2021 - Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. Limitations of Use Glimepiride tablets USP should not be used for the trea...
https://doi.org/10.1186/s12875-021-01424-w 10.1186/1756-0500-7-497 10.1155/2016/6989453 10.1016/j.diabres.2020.108072 10.1186/1477-7525-1-13 10.1136/thx.54.7.581 10.1016/j.cnur.2017.04.007 10.1093/gerona/gls161 10.1370/afm.983 10.1016/j.gaceta.2013.03.002 10.1016/j.ccm.2013.10.002 10.1111/dme.12472 10.1016/j.rmed.2016.07.015
BMC Family Practice; Willink RP, Vos RC et. al.
Apr 21st, 2021 - Type 2 diabetes (T2DM) and COPD are chronic medical conditions, for which patients need lifelong healthcare. The aim of this study is to examine in which healthcare setting patients with T2DM and COPD receive their care, and if this is the correct...
https://doi.org/10.1186/s12876-021-01763-z 10.1002/hep.28431 10.1056/NEJMra1503519 10.1002/hep.23527 10.1016/j.jhep.2016.07.033 10.1007/s10620-013-2743-5 10.1002/hep.27368 10.1016/j.diabres.2018.02.023 10.1016/S2213-8587(14)70032-4 10.1038/nrgastro.2013.41 10.1016/S0168-8278(86)80075-7 10.1016/j.cgh.2008.12.015 10.1053/j.gastro.2005.03.084 10.1002/hep.25762 10.1016/j.jhep.2016.06.005 10.1111/apt.13405 10.1177/1403494815602830 10.1093/ije/dyr039 10.1093/sleep/14.6.540 10.1016/0165-1781(89)90047-4 10.1097/ALN.0b013e31816d83e4 10.1007/s11136-011-9903-x 10.1016/j.ultrasmedbio.2010.07.005 10.1002/hep.29367 10.1053/j.gastro.2014.11.039 10.1016/j.metabol.2020.154183 10.1002/hep4.1134 10.1111/obr.12407 10.1038/nrgastro.2013.171 10.2174/1381612826666200310142803 10.1016/j.jhep.2018.03.018 10.1038/srep33386 10.1093/eurheartj/ehr453 10.1002/hep.28253 10.1016/j.atherosclerosis.2016.01.016 10.1002/oby.22210 10.1016/j.jcmg.2016.10.024
BMC Gastroenterology; Nasr P, Iredahl F et. al.
Apr 21st, 2021 - Non-alcoholic fatty liver disease (NAFLD) affects 20-30% of the general adult population. NAFLD patients with type 2 diabetes mellitus (T2DM) are at an increased risk of advanced fibrosis, which puts them at risk of cardiovascular complications, h...
https://doi.org/10.1111/bph.15497
British Journal of Pharmacology; Jones B
Apr 21st, 2021 - Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective treatments for type 2 diabetes as they stimulate insulin release and promote weight loss through appetite suppression. Their main side effect is nausea. All approved GLP-1RAs are f...
https://doi.org/10.1111/tri.13883
Transplant International : Official Journal of the Europe... Ertuglu LA, Porrini E et. al.
Apr 21st, 2021 - Post-transplant diabetes mellitus (PTDM) is a common complication of solid organ transplantation and a major cause of increased morbidity and mortality. Additionally, solid organ transplant patients may have pre-existent type 2 diabetes mellitus (...
News 9,609 results
https://www.medscape.com/viewarticle/949649
Apr 20th, 2021 - Calorie-restricted diets followed by gradual food reintroduction may not only lead to remission of type 2 diabetes but also normalise cardiovascular disease risk and heart age, the results of a UK analysis suggest. Moreover, the approach is transf...
https://www.medscape.com/viewarticle/948849
Apr 5th, 2021 - Cardiovascular disease was the leading cause of death among the over 16,000 patients with type 2 diabetes (T2DM) who were enrolled in the SAVOR-TIMI 53 trial. Two-thirds (66.3%) of all 798 deaths after a median 2.1 years of follow-up were caused b...
https://www.medscape.com/viewarticle/948824
Apr 5th, 2021 - As a result of the COVID-19 pandemic, the United States will likely face a tsunami of death and disability from common chronic diseases that will affect society for decades, Robert Califf, MD, former commissioner of the US Food and Drug Administra...
https://www.medscape.com/viewarticle/948542
Apr 1st, 2021 - NEW YORK (Reuters Health) - Lowering elevated lipoprotein(a) levels with the PCSK9 inhibitor alirocumab may be associated with a slightly increased risk of developing type-2 diabetes, but the benefit appears to outweigh the potential risk, new res...
https://www.medscape.com/viewarticle/948605
Apr 1st, 2021 - Takeaway Type 2 diabetes (T2D) patients prescribed metformin, sodium-glucose cotransporter-2 inhibitors (SGLT2i) and sulfonylureas were at a lower risk of COVID-19-related mortality than those not prescribed these drugs.